연구동향 분석
박사

Biochemical and structural study of p53 tumor suppressor-Bcl-2 family protein complex = p53 종양 억제자와 Bcl-2 패밀리 단백질 복합체의 생화학 및 구조 연구

박소영 2015년

논문상세정보
    • 저자 박소영
    • 형태사항 삽화: vi, 67 장: 26 cm
    • 일반주기 지도교수: 장세복, 참고문헌: 장 58-65
    • 학위논문사항 생명시스템학과, 부산대학교 대학원, 학위논문(박사)-, 2015. 2
    • DDC 23, 571.6
    • 발행지 부산
    • 언어 eng
    • 출판년 2015
    • 발행사항 부산대학교 대학원
    • 주제어 세포사멸 세포사멸조절자
    유사주제 논문( 59)
인용/피인용
' Biochemical and structural study of p53 tumor suppressor-Bcl-2 family protein complex = p53 종양 억제자와 Bcl-2 패밀리 단백질 복합체의 생화학 및 구조 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 세포사멸
  • 세포사멸조절자
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
61 0

0.0%

' Biochemical and structural study of p53 tumor suppressor-Bcl-2 family protein complex = p53 종양 억제자와 Bcl-2 패밀리 단백질 복합체의 생화학 및 구조 연구' 의 참고문헌

  • Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., Vogelstein, B. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7, 673-682.
  • Yu, J., Zhang, L. (2008) PUMA, a potent killer with or without p53. Oncogene 27, S71-S83.
  • Yu, J., Zhang, L. (2003) No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4, 248-249.
  • Yao, H., Mi, S., Gong, W., Lin, J., Xu, N., Perrett, S., Xia, B., Wang, J., Feng, Y. (2013) Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles. Biochemistry 52, 6324-6334.
  • Wang, Y., Rosengarth, A., Luecke, H. (2007) Structure of the human p53 core domain in the absence of DNA. Acta Crystallogr D Biol Crystallogr 63, 276-281.
  • Wallentine, B. D., Wang, Y., Tretyachenko-Ladokhina, V., Tan, M., Senear, D. F., Luecke, H. (2013) Structures of oncogenic, suppressor and rescued p53 corevariants: mechanisms of mutant p53 rescue. Acta Crystallogr D Biol Crystallogr 69, 2146-2156.
  • Vousden, K. H., Prives, C. (2009) Blinded by the light: the growing complexity of p53. Cell 137, 413-431.
  • Vogelstein, B., Lane, D., Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310.
  • Villunger, A., Michalak, E. M., Coultas, L., M llauer, F., B ck, G., Ausserlechner, M. J., Adams, J. M., Strasser, A. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036- 1038.
  • Valente, L. J., Gray, D. H., Michalak, E. M., Pinon-Hofbauer, J., Egle, A., Scott, C. L., Janic, A., Strasser, A. (2013) p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep 3, 1339-1345.
  • Speidel, D. (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20, 14-24.
  • Smits, C., Czabotar, P. E., Hinds, M. G., Day, C. L. (2008) Structural plasticity underpins promiscuous binding of the prosurvival protein A1. Structure 16, 818- 829.
  • Shibue, T., Taniguchi, T. (2006) BH3?only proteins: Integrated control point of apoptosis. Int J Cancer 119, 2036-2043.
  • Shibue, T., Takeda, K., Oda, E., Tanaka, H., Murasawa, H., Takaoka, A., Morishita, Y., Akira, S., Taniguchi, T., Tanaka, N. (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17, 2233-2238.
  • Seo, Y. W., Woo, H. N., Piya, S., Moon, A. R., Oh, J. W., Yun, C. W., Kim, K. K., Min, J. Y., Jeong, S. Y., Chung, S., Song, P. I., Jeong S. Y., Choi, E. K., Seol, D. W., Kim, T. H. (2009) The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release. Cancer Res 69, 8356-8365.
  • Seo, Y. W., Shin, J. N., Ko, K. H., Cha, J. H., Park, J. Y., Lee, B. R., Yun, C. W., Kim Y. M., Seol D. W., Kim D. W., Yin X. M. Kim, T. H. (2003) The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278, 48292-48299.
  • Puthalakath, H., Strasser, A. (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3- only proteins. Cell Death Differ 9, 505-512.
  • Ploner, C., Kofler, R., Villunger, A. (2008) Noxa: at the tip of the balance between life and death. Oncogene 27, S84-S92.
  • Placzek, W., Wei, J., Kitada, S., Zhai, D., Reed, J. C., Pellecchia, M. (2010) A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis. 1, e40.
  • Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., Tanaka, N. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058.
  • Navaza, J. (1994) AMoRe: an automated package for molecular replacement. Acta Crystallogr A 50, 157-163.
  • Natan, E., Baloglu, C., Pagel, K., Freund, S., Morgner, N., Robinson, C. V., Fersht, A. R., Joerger, A. C. (2011) Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer. J Mol Biol 409, 358-368.
  • Nakajima, W., Tanaka, N. (2007) Synergistic induction of apoptosis by p53- inducible Bcl-2 family proteins Noxa and Puma. J Nippon Med Sch 74, 148-157. Nakano, K., Vousden, K. H. (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7, 683-694.
  • Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, D. N., Bhutia, S. K. (2014) Autophagy and apoptosis: where do they meet? Apoptosis 19, 555-566.
  • Michalak, E. M., Villunger, A., Adams, J. M., Strasser, A. (2008) In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15, 1019-1029.
  • Leu, J. J., Dumont, P., Hafey, M., Murphy, M. E., George, D. L. (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak?Mcl1 complex. Nat Cell Biol 6, 443-450.
  • Kissinger, C. R., Gehlhaar, D. K., Fogel, D. B. (1999) Rapid automated molecular replacement by evolutionary search. Acta Crystallogr D Biol Crystallogr 55, 484- 491.
  • Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., Maclean, K. H., Han, J., Chittenden, T., Ihle, J. N., Mckinnon, P. J., Cleveland, J. L., Zambetti, G. P. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328.
  • Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C. C. (1991) p53 mutations in human cancers. Science 253, 49-53.
  • Hofseth, L. J., Hussain, S. P. Harris, C. C. (2004) p53: 25 years after its discovery. Trends Pharmacol Sci 25, 177-181.
  • Ho, W. C., Luo, C., Zhao, K., Chai, X., Fitzgerald, M. X., Marmorstein, R. (2006) High-resolution structure of the p53 core domain: implications for binding smallmolecule stabilizing compounds. Acta Crystallogr D Biol Crystallogr 62, 1484- 1493.
  • Hikisz, P., Kilia?ska, Z. M. (2012) PUMA, a critical mediator of cell death-one decade on from its discovery. Cell Mol Biol Lett 17, 646-669.
  • Hengartner, M.O., 2000. The biochemistry of apoptosis, Nature 407, 770-776.
  • Ha, J. H., Shin, J. S., Yoon, M. K., Lee, M. S., He, F., Bae, K. H., Yoon, H. S., Lee, C. K., Park, S. G., Muto, Y., Chi, S. W. (2013) Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways. J Biol Chem 288, 7387-7398.
  • Green, D. R. (2000) Apoptotic pathways: paper wraps stone blunts scissors. Cell 102, 1-4.
  • Erlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., Villunger, A. (2005) BH3-only proteins Puma and Bim are rate-limiting for γ-radiation and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106, 4131-4138.
  • Culmsee C, Mattson MP. 2005. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331: 761–777.
  • Cregan, S. P., Arbour, N. A., MacLaurin, J. G., Callaghan, S. M., Fortin, A., Cheung, E. C., Guberman, D. S., Park D. S., Slack, R. S. (2004) p53 activation domain 1 is essential for PUMA upregulation and p53-mediated neuronal cell death. J Neurosci 24, 10003-10012.
  • Collins K, Jacks T, Pavletich NP. (1997) The cell cycle and cancer. ProcNatl Acad Sci U S A 94:2776-2778.
  • Cho, Y., Gorina, S., Jeffrey, P. D., Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
  • Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010- 1014.
  • Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., Green, D. R. (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 9, 1732-1735.
  • Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse- Kunstleve, R. W., Jiang J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonso, T., Warren, G. L. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54, 905-921.
  • Borner, C. (2003) The Bcl-2 protein family: sensors and checkpoints for life-ordeath decisions. Mol Immunol 39, 615-647.
  • Bai, L., Zhu, W. G. (2006) p53: structure, function and therapeutic applications. J Cancer Mol 2, 141-153.
  • Adams JM, Cory S. 2007. The Bcl -2 apoptotic switch in cancer development and therapy. Oncogene. 26: 1324-1337.